Sign In
Buy ABT
$93.24
+2.73 (+3.02%)
At Close: Jun 25, 2026
All 18 Big Ten universities will go head-to-head in Year 2 of the nationwide challenge, the 'We Give Blood' drive, to inspire the most blood donations from students, alumni, and fans with the winning
Abbott Taps Growing TMVR Market With Tendyne System
09:36am, Thursday, 14'th Aug 2025
ABT wins FDA nod for its Tendyne TMVR system, offering a minimally invasive option for patients with severe mitral valve disease.
Abbott India's profit climbs on healthy pharmaceutical demand
04:18am, Tuesday, 12'th Aug 2025
Drugmaker Abbott India reported an 11.5% rise in first-quarter profit on Tuesday, driven by healthy sales in its mainstay pharmaceuticals segment.
Abbott Laboratories Q2 Earnings: Dividends Don't Lie
08:47am, Saturday, 09'th Aug 2025
Abbott's Q2 performance reflects some evenness and the potential headwinds from macroeconomic uncertainties. However, short-term issues like tariffs and drug price control do not fundamentally alter A
3 Stocks Retirees Should Absolutely Love
06:45am, Saturday, 09'th Aug 2025
Priorities change as you enter new seasons of life. That's especially true for your retirement years.
Dividend Champion, Contender, And Challenger Highlights: Week Of August 10
06:07pm, Friday, 08'th Aug 2025
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Abbott's EPD Growth Beats Market Trends: Here's How to Play the Stock
10:41am, Friday, 08'th Aug 2025
Abbott outpaces market trends as EPD sales surge, fueled by double-digit growth, biosimilar approvals and strong product demand.
NVST vs. ABT: Which Stock Is the Better Value Option?
12:40pm, Thursday, 07'th Aug 2025
Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Wednesday, 06'th Aug 2025
Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Abbott's Q2 Diabetes Care Sales Rise 19.6%: What's Backing It?
08:46am, Wednesday, 06'th Aug 2025
ABT's Diabetes Care sales surge 19.6% in Q2, fueled by strong U.S. demand and new OTC approvals for its CGM systems.
Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb
08:31am, Friday, 01'st Aug 2025
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss news of President Trump ordering pharma companies to lower U.S. drug prices in the next 60 days, the move to tiered pricing glo
2 Top Stocks to Buy Now If You Want Decades of Passive Income
08:15am, Friday, 01'st Aug 2025
Any company that can pay and raise its dividends over long periods almost certainly has strong underlying operations. So, corporations of this caliber can offer a lot more than just passive income.
President Trump demands drugmakers slash prices within 60 days
06:54am, Friday, 01'st Aug 2025
CNBC's Joe Kernen reports on the latest news.
3 Dividend Growth Stocks That Will Deliver Meaty Returns After 5 Years
01:38pm, Monday, 28'th Jul 2025
Sufficient earnings growth to continually increase dividends at a comfortably low payout ratio that also accommodates expansion capex is an excellent signal for strong upside potential.
Best Dividend Aristocrats For August 2025
05:19am, Monday, 28'th Jul 2025
Dividend Aristocrats are outperforming SPY in July but still trail year-to-date; select Aristocrats delivered double-digit gains and strong dividend growth. 47 of 69 Aristocrats raised dividends in 20
